Related Experiment Video
Updated: Aug 11, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Serum amyloid A: the "other" inflammatory protein
1Division of Cardiology, University of Washington, Seattle 98195-6422, USA. cardiac@u.washington.edu
Serum amyloid A (SAA) is an inflammatory protein linked to atherosclerosis. This review explores SAA
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Science
Background:
- Inflammation is a known hallmark of atherosclerotic lesions.
- Chronic low-level elevations of plasma inflammatory proteins like C-reactive protein (CRP) and serum amyloid A (SAA) are increasingly recognized.
- These proteins may act as atherosclerosis risk markers and actively participate in atherogenesis.
Purpose of the Study:
- To review the evidence for and against the roles of CRP in atherosclerosis.
- To focus on the role of SAA in atherogenesis, including its regulation and function.
- To explore SAA's potential as a mediator linking inflammation, dyslipidemia, obesity, and insulin resistance to atherosclerosis.
Main Methods:
- Literature review of existing studies on CRP and SAA.
- Analysis of data concerning SAA regulation by dietary cholesterol, obesity, and insulin resistance.
- Examination of SAA's interaction with high-density lipoprotein (HDL).
Main Results:
- Evidence for CRP's role as an atherosclerosis risk marker and in atherogenesis is reviewed.
- SAA is an inflammatory protein associated with high-density lipoprotein (HDL), potentially altering its function.
- SAA's regulation is influenced by dietary cholesterol, obesity, and insulin resistance.
Conclusions:
- SAA may play a critical role in mediating the contributions of inflammation, dyslipidemia, obesity, and insulin resistance to atherogenesis.
- SAA's position at the intersection of these risk factors highlights its significance in cardiovascular disease development.
- Further research into SAA's mechanisms is warranted to understand its full impact on atherosclerosis.
More Related Videos
10:51Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting
Published on: April 10, 2014
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Proteoglycans
Amebiasis
Type I Diabetes II: Pathophysiology
Acute Pancreatitis II: Pathophysiology